Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates


Development of resistance to ceftolozane/tazobactam therapy: case report

    This is a preview of subscription content, log in to check access.


    1. Cabrera N, et al. Clinical and microbiological outcomes associated with real-world use of ceftolozane/tazobactam. Open Forum Infectious Diseases 6 (Suppl. 2): S768-S769 (plus poster) abstr. 2248, Oct 2019. Available from: URL: [abstract]

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Verify currency and authenticity via CrossMark

    Cite this article

    Ceftolozane/tazobactam. Reactions Weekly 1791, 63 (2020).

    Download citation